Steven Hanks
Last active: 1/20/2015

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. p130Cas substrate domain signaling promotes migration, invasion, and survival of estrogen receptor-negative breast cancer cells. Cunningham-Edmondson AC, Hanks SK (2009) Breast Cancer (Dove Med Press) : 39-52
    › Primary publication · 24367162 (PubMed) · PMC3022348 (PubMed Central)
  2. Global phosphotyrosine proteomics identifies PKCδ as a marker of responsiveness to Src inhibition in colorectal cancer. McKinley ET, Liu H, McDonald WH, Luo W, Zhao P, Coffey RJ, Hanks SK, Manning HC (2013) PLoS One 8(11): e80207
    › Primary publication · 24260357 (PubMed) · PMC3832668 (PubMed Central)
  3. Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease. George B, Verma R, Soofi AA, Garg P, Zhang J, Park TJ, Giardino L, Ryzhova L, Johnstone DB, Wong H, Nihalani D, Salant DJ, Hanks SK, Curran T, Rastaldi MP, Holzman LB (2012) J Clin Invest 122(2): 674-92
    › Primary publication · 22251701 (PubMed) · PMC3266791 (PubMed Central)
  4. Tyrosine phosphorylation within the SH3 domain regulates CAS subcellular localization, cell migration, and invasiveness. Janoštiak R, Tolde O, Brůhová Z, Novotný M, Hanks SK, Rösel D, Brábek J (2011) Mol Biol Cell 22(22): 4256-67
    › Primary publication · 21937722 (PubMed) · PMC3216652 (PubMed Central)
  5. KSR1 is a functional protein kinase capable of serine autophosphorylation and direct phosphorylation of MEK1. Goettel JA, Liang D, Hilliard VC, Edelblum KL, Broadus MR, Gould KL, Hanks SK, Polk DB (2011) Exp Cell Res 317(4): 452-63
    › Primary publication · 21144847 (PubMed) · PMC3038243 (PubMed Central)
  6. P130Cas Src-binding and substrate domains have distinct roles in sustaining focal adhesion disassembly and promoting cell migration. Meenderink LM, Ryzhova LM, Donato DM, Gochberg DF, Kaverina I, Hanks SK (2010) PLoS One 5(10): e13412
    › Primary publication · 20976150 (PubMed) · PMC2956669 (PubMed Central)
  7. Dynamics and mechanism of p130Cas localization to focal adhesions. Donato DM, Ryzhova LM, Meenderink LM, Kaverina I, Hanks SK (2010) J Biol Chem 285(27): 20769-79
    › Primary publication · 20430882 (PubMed) · PMC2898362 (PubMed Central)
  8. Focal adhesion kinase-dependent regulation of adhesive forces involves vinculin recruitment to focal adhesions. Dumbauld DW, Michael KE, Hanks SK, García AJ (2010) Biol Cell 102(4): 203-213
    › Primary publication · 19883375 (PubMed) · PMC4915345 (PubMed Central)
  9. Absolute quantification of phosphorylation on the kinase activation loop of cellular focal adhesion kinase by stable isotope dilution liquid chromatography/mass spectrometry. Ciccimaro E, Hanks SK, Yu KH, Blair IA (2009) Anal Chem 81(9): 3304-13
    › Primary publication · 19354260 (PubMed) · PMC2706532 (PubMed Central)
  10. Focal adhesion kinase modulates cell adhesion strengthening via integrin activation. Michael KE, Dumbauld DW, Burns KL, Hanks SK, García AJ (2009) Mol Biol Cell 20(9): 2508-19
    › Primary publication · 19297531 (PubMed) · PMC2675629 (PubMed Central)
  11. Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis. Ricono JM, Huang M, Barnes LA, Lau SK, Weis SM, Schlaepfer DD, Hanks SK, Cheresh DA (2009) Cancer Res 69(4): 1383-91
    › Primary publication · 19208836 (PubMed) · PMC2741736 (PubMed Central)
  12. Quantification of focal adhesion kinase activation loop phosphorylation as a biomarker of Src activity. Ciccimaro E, Hanks SK, Blair IA (2009) Mol Pharmacol 75(3): 658-66
    › Primary publication · 19098120 (PubMed) · PMC2684915 (PubMed Central)
  13. Src transformation of colonic epithelial cells: enhanced anchorage-independent growth in an Apc(+/min) background. Constancio-Lund SS, Brabek J, Hanks SK (2009) Mol Carcinog 48(2): 156-66
    › Primary publication · 18613032 (PubMed) · PMC2644448 (PubMed Central)
  14. Global impact of oncogenic Src on a phosphotyrosine proteome. Luo W, Slebos RJ, Hill S, Li M, Brábek J, Amanchy R, Chaerkady R, Pandey A, Ham AJ, Hanks SK (2008) J Proteome Res 7(8): 3447-60
    › Primary publication · 18563927 (PubMed) · PMC2579752 (PubMed Central)
  15. The integrin-coupled signaling adaptor p130Cas suppresses Smad3 function in transforming growth factor-beta signaling. Kim W, Seok Kang Y, Soo Kim J, Shin NY, Hanks SK, Song WK (2008) Mol Biol Cell 19(5): 2135-46
    › Primary publication · 18321991 (PubMed) · PMC2366878 (PubMed Central)
  16. A FAK/Src chimera with gain-of-function properties promotes formation of large peripheral adhesions associated with dynamic actin assembly. Siesser PM, Meenderink LM, Ryzhova L, Michael KE, Dumbauld DW, García AJ, Kaverina I, Hanks SK (2008) Cell Motil Cytoskeleton 65(1): 25-39
    › Primary publication · 17922492 (PubMed) · PMC2387247 (PubMed Central)
  17. p130CAS is required for netrin signaling and commissural axon guidance. Liu G, Li W, Gao X, Li X, Jürgensen C, Park HT, Shin NY, Yu J, He ML, Hanks SK, Wu JY, Guan KL, Rao Y (2007) J Neurosci 27(4): 957-68
    › Primary publication · 17251438 (PubMed) · PMC2014516 (PubMed Central)
  18. Requirement of Nck adaptors for actin dynamics and cell migration stimulated by platelet-derived growth factor B. Rivera GM, Antoku S, Gelkop S, Shin NY, Hanks SK, Pawson T, Mayer BJ (2006) Proc Natl Acad Sci U S A 103(25): 9536-41
    › Primary publication · 16769879 (PubMed) · PMC1476694 (PubMed Central)
  19. The signaling and biological implications of FAK overexpression in cancer. Siesser PM, Hanks SK (2006) Clin Cancer Res 12(11 Pt 1): 3233-7
    › Primary publication · 16740741 (PubMed)